Table 2.
The IC50 and CRs of two ZEN mAbs against ZEN analogs.
| Compounds | 2B6 | 4D9 | ||
|---|---|---|---|---|
| IC50 (μg/L) a | CR (%) b | IC50 (μg/L) a | CR (%) b | |
| ZEN | 10.38 ± 0.68 | 100 | 17.23 ± 1.18 | 100 |
| α-ZAL | 682.89 ± 45.22 | 1.52 | 1057.06 ± 65.54 | 1.63 |
| β-ZAL | 810.94 ± 52.72 | 1.28 | 1276.30 ± 76.58 | 1.35 |
| α-ZOL | 393.18 ± 23.58 | 2.64 | 602.45 ± 3 6.75 | 2.86 |
| β-ZOL | 567.21 ± 39.72 | 1.83 | 857.21 ± 57.44 | 2.01 |
| ZON | 243.09 ± 15.81 | 4.27 | 353.07 ± 21.88 | 4.88 |
| Aflatoxin B1 | >10,000 | <0.1 | >10,000 | <0.1 |
| Deoxynivalenol | >10,000 | <0.1 | >10,000 | <0.1 |
| T-2 toxin | >10,000 | <0.1 | >10,000 | <0.1 |
| Ochratoxin A | >10,000 | <0.1 | >10,000 | <0.1 |
Note: (a) The standard solution was prepared using 70% methanol-PBS (7:3, v/v); (b) The data were calculated using the CR of ZEN mAbs against ZEN as 100%.